Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study.

Source:http://linkedlifedata.com/resource/pubmed/id/16951642

J. Acquir. Immune Defic. Syndr. 2006 Oct 1 43 2 169-78

Download in:

View as

Triples

General Info

PMID
16951642